Shanghai Medicilon Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 742.88 million compared to CNY 484.36 million a year ago. Revenue was CNY 742.88 million compared to CNY 485.04 million a year ago.

Net income was CNY 162.6 million compared to CNY 113.1 million a year ago. Basic earnings per share from continuing operations was CNY 1.3357 compared to CNY 0.9286 a year ago. Diluted earnings per share from continuing operations was CNY 1.3357 compared to CNY 0.9286 a year ago.